Top Markets
#1 Orochi Network Orochi Network +75.87%
#2 Bitway Bitway +27.42%
#3 Audiera Audiera +26.10%
#4 RSK Infrastructure Framework RSK Infrastructure Framework +18.52%
#5 Zilliqa Zilliqa +15.74%
#6 SOON SOON +15.22%
#7 DeXe DeXe +14.77%
#8 Pharos Pharos +14.68%
#9 Taiko Taiko +14.38%
#10 Cap Cap +13.75%
Coin of the day
Orochi Network Orochi Network
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Novo Nordisk A/S Novo Nordisk A/S

Novo Nordisk A/S

NVO
Classifica tra le azioni #72
Novo Nordisk A/S, a healthcare company, engages in the research, development,... Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabetic products, obesity, and other chronic diseases. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth disorders, and hormone replacement therapy. The company collaboration agreements with Gilead Sciences, Inc. Novo Nordisk A/S also has a research collaboration with Lumen Bioscience, Inc. to explore strategies for delivering oral biologics for cardiometabolic disease. The company was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
Prezzo delle azioni
$50.93
Capitalizzazione di mercato
$226.32B
Variazione (1 giorno)
2.54%
Variazione (1 anno)
-26.19%
Paese
DK
Scambia Novo Nordisk A/S (NVO)

Categoria

Healthcare
Storico del prezzo dell'azione per Novo Nordisk A/S (NVO)
Prezzo di chiusura più alto: $49.52 il 2026-07-01

Prezzo di chiusura più basso: $0.32 il 1981-04-01
Storico del prezzo dell'azione di Novo Nordisk A/S dal 1981 al 2026
Andamento annuale del prezzo dell'azione
Anno Performance
2026 (TTM) -1.00%
2025 -51.41%
2024 1.37%
2023 -23.75%
2022 18.42%
2021 58.67%
2020 21.62%
2019 25.84%
2018 -13.49%
2017 49.22%
2016 -38.08%
2015 28.13%
2014 24.34%
2013 10.53%
2012 43.10%
2011 4.91%
2010 63.57%
2009 27.55%
2008 -21.05%
2007 58.90%
2006 48.91%
2005 2.63%
2004 37.90%
2003 32.55%
2002 -24.64%
2001 5.13%
2000 41.08%
1999 7.19%
1998 -8.33%
1997 47.95%
1996 35.57%
1995 48.03%
1994 -4.48%
1993 3.78%
1992 6.11%
1991 41.63%
1990 22.83%
1989 25.62%
1988 71.60%
1987 -27.11%
1986 10.02%
1985 17.83%
1984 -58.65%
1983 32.75%
1982 8.37%
1981 0.00%
Prezzo dell'azione per aziende simili o concorrenti
Azienda Prezzo dell'azione Variazione 1a% Il paese
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $490.39 6.41%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
 $695.18 24.44%
US
UCB SA UCB SA
UCB SA
UCB.BR
 $296.78 43.84%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $872.23 46.55%
NL
Alnylam Pharmaceuticals, Inc. Alnylam Pharmaceuticals, Inc.
Alnylam Pharmaceuticals, Inc.
ALNY.US
 $288.41 -11.20%
US